Author labels major AI firms "worthless" due to massive cash burn and lack of profitability, citing Anthropic's $42B 2025 net ...
Let's dive into how six of the most noteworthy players who switched teams ahead of this season have fared so far.
In 2026, a new treatment for HER2-positive breast cancer, 'Tukysa' (generic name: tucatinib), was approved in Japan.I am ...
For readers drawn to a wearable approach, this review explores Super Patch's brand-stated drug-free design, product-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results